Cell Transplant in Spinal Cord Injury Patients

Autologous Bone Marrow Derived Cell Transplant in Spinal Cord Injury Patients

This study is designed to assess the safety of autologous bone marrow derived cell transplant in chronic spinal cord injury patients. The hypothesis is that the availability of bone marrow derived mesenchymal stem cells at the sites of injury promote neuronal regeneration.

Inclusion Criteria:

• Traumatic spinal cord injury
• No concomitant systemic disease
• No progress on physiotherapy for at least 6 months
• Duration of injury from 10 months to 3 years

Exclusion Criteria:

• Non-traumatic spinal cord injury whether transverse myelitis or demyelination
• Concomitant systemic disease
• Progress can be observed on physiotherapy
• Acute injury or duration of injury less than 10 months